Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BID | P55957 | 3/20 | 0.41 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.41 |
| ▸ | KAT8 | Q9H7Z6 | 3/20 | 0.41 |
| ▸ | BCL2L1 | Q07817 | 2/20 | 0.41 |
| ▸ | BAK1 | Q16611 | 2/20 | 0.41 |
| ▸ | EP300 | Q09472 | 2/20 | 0.41 |
| ▸ | KAT5 | Q92993 | 2/20 | 0.41 |
| ▸ | SAE1 | Q9UBE0 | 2/20 | 0.41 |
| ▸ | PPARG | P37231 | 1/20 | 0.41 |
| ▸ | PPARA | Q07869 | 1/20 | 0.41 |
| ▸ | KAT2A | Q92830 | 1/20 | 0.41 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.41 |
| ▸ | IAPP | P10997 | 1/20 | 0.39 |
| ▸ | CNR1 | P21554 | 2/20 | 0.38 |
| ▸ | CNR2 | P34972 | 2/20 | 0.38 |
| ▸ | MMP2 | P08253 | 2/20 | 0.37 |
| ▸ | F7 | P08709 | 2/20 | 0.37 |
| ▸ | F3 | P13726 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL101784 | 0.92 | BID (0.42) | BIDMCL1KAT8BCL2L1BAK1 | |
| Hydrochloric Acid SCHEMBL1276007 | 0.91 | BID (0.41) | BIDMCL1KAT8BCL2L1BAK1 | |
| SCHEMBL23779420 | 0.88 | BID (0.47) | BIDMCL1KAT8BCL2L1BAK1 | |
| SCHEMBL3807359 | 0.84 | NAAA (0.41) | BIDMCL1KAT8BCL2L1BAK1 | |
| SCHEMBL28790813 | 0.84 | PTPN1 (0.41) | BIDMCL1KAT8BCL2L1BAK1 | |
| SCHEMBL27842727 | 0.82 | KAT8 (0.40) | BIDMCL1KAT8BCL2L1BAK1 | |
| SCHEMBL4257038 | 0.81 | NAAA (0.43) | BIDMCL1KAT8BCL2L1BAK1 | |
| SCHEMBL1923190 | 0.81 | NAAA (0.43) | BIDMCL1KAT8BCL2L1BAK1 | |
| SCHEMBL28524989 | 0.79 | ALOX5 (0.50) | BIDMCL1KAT8BCL2L1BAK1 | |
| SCHEMBL995527 | 0.79 | BID (0.43) | BIDMCL1KAT8BCL2L1BAK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11723856-B2 | Use of UV resistant active materials on hair | COAST SOUTHWEST INC. (US) | 2023-08-15 | — | — | US | disclosed |
| US-20210045994-A1 | USE OF UV RESISTANT ACTIVE MATERIALS ON HAIR | COAST SOUTHWEST INC. | 2021-02-18 | — | — | US | disclosed |
| US-10835481-B2 | Use of UV resistant active materials on hair | COAST SOUTHWEST, INC. (US) | 2020-11-17 | — | — | US | disclosed |
| WO-2018170439-A1 | USE OF UV RESISTANT ACTIVE MATERIALS ON HAIR | COAST SOUTHWEST, INC. (US) | 2018-09-20 | — | — | WO | disclosed |
| US-20180263891-A1 | USE OF UV RESISTANT ACTIVE MATERIALS ON HAIR | COAST SOUTHWEST INC. | 2018-09-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180263891-A1 | USE OF UV RESISTANT ACTIVE MATERIALS ON HAIR | UNG, ERCC4, XPA | BID 3826/4885MCL1 2932/4885KAT8 2508/4885 |
| US-10835481-B2 | Use of UV resistant active materials on hair | UNG, ERCC4, XPA | BID 3826/4885MCL1 2932/4885KAT8 2508/4885 |
| US-20210045994-A1 | USE OF UV RESISTANT ACTIVE MATERIALS ON HAIR | UNG, ERCC4, XPA | BID 4085/4885MCL1 3221/4885KAT8 2347/4885 |
| US-11723856-B2 | Use of UV resistant active materials on hair | UNG, ERCC4, XPA | BID 4085/4885MCL1 3221/4885KAT8 2347/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.